Trinity Biotech plc announced revised agreements with its primary lender, Perceptive Advisors, to improve its financial position as the company implements its Comprehensive Transformation Plan and ...
Trinity Biotech plc, a biotechnology company specializing in human diagnostics and diabetes management, announced it has secured an additional $4 million in debt financing from Perceptive Advisors.
According to Gartner, 58% of finance functions employed AI in 2024—a 21-percentage-point jump from the prior year. PwC ...
DUBLIN, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
ADA IMPROVEMENTS. WE’RE GETTING A FIRST LOOK INSIDE A FIRST OF ITS KIND SCIENCE LAB SPACE ABOUT TO OPEN IN SACRAMENTO REGION. THAT FACILITY, THE LATEST SIGN OF THIS REGION REINVENTING ITSELF INTO A ...
NEW YORK, Sept. 20, 2023 /PRNewswire/ -- More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and ...
DUBLIN, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
TrinScreen HIV order signals renewed strength in global HIV testing market- Company also reports a key milestone of Adjusted EBITDA1positive ...
SAN FRANCISCO--(BUSINESS WIRE)--Biotechnology is set for significant transformation in 2025 with an incoming political administration, rapid scientific advancements, and the convergence of technology ...